Status:

NOT_YET_RECRUITING

A Prospective, Single-Center, Single-Arm, Investigator-Initiated Exploratory Clinical Trial to Assess the Safety of Repetitive Transcranial Magnetic Stimulation for Children and Adolescents With Autism Spectrum Disorder

Lead Sponsor:

Bundang CHA Hospital

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

3-17 years

Phase:

NA

Brief Summary

This is a prospective, single-center, single-arm, investigator-initiated exploratory clinical trial aimed at evaluating the safety and exploring the efficacy of a medical electromagnetic stimulator de...

Eligibility Criteria

Inclusion

  • Aged between 3 and 17 years at the time of enrollment
  • Clinically diagnosed with Autism Spectrum Disorder (ASD), including assessment using the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)
  • Currently receiving outpatient care for ASD at the Department of Rehabilitation Medicine, CHA Bundang Medical Center
  • The participant and their legal guardian have been fully informed of the study and have voluntarily provided written informed consent

Exclusion

  • Diagnosed with a major neurological condition other than ASD
  • Epileptiform discharges detected on EEG screening requiring initiation or adjustment of antiepileptic medication
  • Diagnosed with other psychiatric disorders, such as schizophrenia or major depressive disorder
  • History of traumatic brain injury, brain tumor, or other significant brain conditions
  • Deemed unsuitable for participation by the principal investigator
  • Currently participating in another interventional clinical trial, or has participated in one within the past 30 days (excluding observational studies)
  • Any of the following contraindications to rTMS:
  • Implanted electronic medical devices (e.g., pacemaker)
  • Presence of metal implants in the skull
  • Skin lesions at the stimulation site
  • History of epilepsy
  • Cervical spine pain or musculoskeletal disorders
  • Pregnancy or currently breastfeeding

Key Trial Info

Start Date :

July 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT06982586

Start Date

July 1 2025

End Date

December 31 2027

Last Update

May 21 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.